Patricia Salgado
About
In The Last Decade
Patricia Salgado
11 papers receiving 166 citations
Peers
Comparison fields: 5 of 47
- Surgery 77
- Molecular Medicine 40
- Pharmacology 39
- Infectious Diseases 37
- Physiology 37
Countries citing papers authored by Patricia Salgado
This map shows the geographic impact of Patricia Salgado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia Salgado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia Salgado more than expected).
Fields of papers citing papers by Patricia Salgado
This network shows the impact of papers produced by Patricia Salgado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia Salgado. The network helps show where Patricia Salgado may publish in the future.
Co-authorship network of co-authors of Patricia Salgado
This figure shows the co-authorship network connecting the top 25 collaborators of Patricia Salgado. A scholar is included among the top collaborators of Patricia Salgado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia Salgado. Patricia Salgado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 45 | |
| 2 | 13 | |
| 3 | 25 | |
| 4 | [Resistant gram-negative bacteria. Therapeutic approach and risk factors]. | 2 |
| 5 | [Therapeutic options for carbapenemase-producing Enterobacteriaceae]. | 2 |
| 6 | A practice-based observational study identifying factors associated with the use of high-dose tigecycline in the treatment of secondary peritonitis in severely ill patients. | 4 |
| 7 | 2 | |
| 8 | 13 | |
| 9 | Fisiopatologia da nefropatia diabética | 3 |
| 10 | 46 | |
| 11 | 24 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.